Catherine Coste - Jul 1, 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
RNLX
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
3
Date filed
7/3/2023, 04:19 PM
Previous filing
Jan 30, 2023
Next filing
Jul 7, 2023

No securities are beneficially owned.

Remarks:

No securities are benefically owned. Exhibit List - Exhibit 24 - Power of Attorney